bio rad s proteon xpr36 array biosensor (Bio-Rad)
Structured Review
Bio Rad S Proteon Xpr36 Array Biosensor, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 96/100, based on 565 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/spr+biosensor+analysis/ProteOn+XPR36+Protein+Interaction+Array+System/pmc02865728-193-8-8
Average 96 stars, based on 565 article reviews
Images
Related Articles
other:Article Title: Influence of SmpB and ClpX interactions and interactomes on the transcription profile of Mycobacterium tuberculosis Article Snippet: These experiments were also performed in the presence of SSB and SmpB using an amine coupling chip using the Article Title: Nutrient Availability Dictates Cancer Metabolism–Based Therapeutic Responses to Nononcology Drugs Article Snippet: The interaction studies between BY03 and TEAD1 were carried out using the SPR Assay:Article Title: TPP-45142—an Anti-HER2 T-cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy Article Snippet: .. The affinity of 27A05 and 29E09 with human, cynomolgus monkey (cyno) and mouse HER2 proteins was determined using surface plasmon resonance (SPR) on a Article Title: Discovery of 4‐Quinazolinone‐Containing Phenylalanine Derivatives as Potent, Resistant‐Tolerant HIV Capsid Inhibitors Article Snippet: .. All experiments were conducted using a Article Title: TPP-45142—an Anti-HER2 T cell Engager—Designed for Selective HER2-Low Cancer Immunotherapy Article Snippet: .. 178 179 180 Affinity determination 181 D ow nloaded from http://aacrjournals.org/m ct/article-pdf/doi/10.1158/1535-7163.M C T-25-0654/3724849/m ct-25-0654.pdf by guest on 12 January 2026 6 The affinity of 27A05 and 29E09 with human and cynomolgus monkey (cyno) proteins was 182 determined using surface plasmon resonance (SPR) on a Binding Assay:Article Title: Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma Article Snippet: .. Binding studies were through Article Title: Revealing erythropoietin variant EV-3 as novel driving force and immunotherapeutic target in human glioblastoma. Article Snippet: .. Binding studies were through |
